TMO stock: buy or sell?
February 18th, 2020
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Should I buy TMO stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Thermo Fisher Scientific stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Thermo Fisher Scientific stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for TMO stock for the last 30 days.
TMO stock analysis
Shares of Thermo Fisher Scientific closed today at $337.37 and decreased a bad -0.54%.
Thermo Fisher Scientific decreased a bad -0.54% and closed at $337.37. From a daily perspective, TMO is in a short term uptrend after plotting its last bottom ($324.57, on February/10) higher than the previous bottom, and its last top ($340.95, on Wednesday) also over the previous top. Now trading in between its last bottom and last top TMO might consolidate in a plain range, waiting to break out over $340.95 or down under $324.57. Since October when SMA50d and SMA100d crossed up, TMO price gained $39.60 per share (13.30%). Since last October when TMO stock price broke up the SMA100d line, it gained $56.55 (20.14%). On January/22, TMO hit new all time highs, pushing higher previous ATH of $341.71 recorded on Jan 21st. New ATHs are usual entry points for many trading setups as there aren't higher resistences.
Thermo Fisher Scientific shares declined -0.54% this week, ending at $337.37. Late January TMO plunged a spooky -6.54% in just one week.
TMO shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $310.92 late January. Previous top ($342.26) will play as a resistance in possible new gains. Not so far away is the last all-time high Thermo Fisher Scientific marked late January. Late October 2019 TMO price bounced up over the SMA of 20 weeks that acted as support stopping new slides.
TMO stock price history
TMO IPO was on March 17th, 1980 at $0.00 per share1. Since then, TMO stock surged a inf%, with an average of inf% per year. If you had invested right after TMO's IPO a $1,000 in TMO stock in 1980, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
TMO stock historical price chart
TMO stock reached all-time highs on January 22nd with a price of $342.26.
TMO stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' TMO stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price prediction for Thermo Fisher Scientific stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter posting its last earnings report on April, Thermo Fisher Scientific . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Thermo Fisher Scientific annual revenues skyrocketed an outstanding 16.45% to $24,358.00 million dollars from $20,918.00 marked in 2017. Nonetheless, its income margin (compared to revenues) raised to 12.06%, that is $2,938.00 million. To have an up to date picture of the financial situation of Thermo Fisher Scientific, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Thermo Fisher Scientific TTM sales up to March 2019 were $24,630.00 and earnings were $3,174.00 million USD. If we compare this TTM figures with the last reported annuality, we can review Thermo Fisher Scientific business evolution since December 2018: Annual revenues up to March, compared to lastest yearly report, inched a slightly fine 1.12%. Regarding profit margin, Thermo Fisher Scientific stayed steady 0.82% to 12.06%
|2013||$13,090 M||-||$1,280 M9.8%||-|
|2014||$16,890 M||29.03%||$1,894 M11.2%||48.00%|
|2015||$16,965 M||0.45%||$1,975 M11.6%||4.28%|
|2016||$18,274 M||7.71%||$2,022 M11.1%||2.35%|
|2017||$20,918 M||14.47%||$2,225 M10.6%||10.05%|
|2018||$24,358 M||16.45%||$2,938 M12.1%||32.04%|
|TTM||$24,630 M||1.12%||$3,174 M12.9%||8.03%|
Quarterly financial resultsThermo Fisher Scientific posted $6,125.00 M in revenues for 2019-Q1, a -5.87% decline compared to previous quarter. Reported quarter earnings marked $815.00 M with a profit margin of 13.31%. Profit margin remained steady a -0.49% compared to previous quarter when profit margin was 13.80%. When comparing sales to same quarter last year, Thermo Fisher Scientific sales marked a beatiful gain and stepped up a 4.65%.
|2017-Q2||$4,990 M||-||$612 M12.3%||-|
|2017-Q3||$5,120 M||2.61%||$534 M10.4%||-12.79%|
|2017-Q4||$6,047 M||18.11%||$528 M8.7%||-1.11%|
|2018-Q1||$5,853 M||-3.21%||$579 M9.9%||9.66%|
|2018-Q2||$6,078 M||3.84%||$752 M12.4%||29.88%|
|2018-Q3||$5,920 M||-2.60%||$709 M12.0%||-5.72%|
|2018-Q4||$6,507 M||9.92%||$898 M13.8%||26.66%|
|2019-Q1||$6,125 M||-5.87%||$815 M13.3%||-9.24%|
Thermo Fisher Scientific ownershipWhen you are planning to buy shares of a stock, it's always worth to overview its ownership structure.
Thermo Fisher Scientific shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.22% of all shares.
Bearish positions for TMO stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Thermo Fisher Scientific:
|Market cap||$135.3 B|
|Total shares||401.0 M|
|Float shares||398.0 M|
|- Institutional holdings (%)||92.2%|
|- Insider holdings (%)||0.2%|
|Shares in short selling||0.0%|
|Tuesday, February 18th, 2020|
|Day range||$334.51 - $338.35|
|Average true range||$7.59|
|50d mov avg||$327.76|
|100d mov avg||$311.38|
|200d mov avg||$296.81|
Thermo Fisher Scientific performanceTo better understand Thermo Fisher Scientific performance you must compare its gains with other related stocks in same sector or industry. For Thermo Fisher Scientific, the benchmark is made against .
|TMOThermo Fisher Sci...||9.68%||25.40%||34.18%|
Thermo Fisher Scientific competitorsUnfortunately, we could not find any public company that could be defined as Thermo Fisher Scientific competitor. This doesn't mean Thermo Fisher Scientific does not have any competitor in the market, it's just we could not detected it.
Latest TMO stock news
- InvestorPlace3 Big Stock Charts for Friday: Thermo Fisher Scientific, Intuit and Intercontinental ExchangeJune 22, 2018